Global Occlusion Devices Market to grow at a CAGR of 6.31% by 2030, Evaluates DelveInsight

According to DelveInsight's analysis, The demand for occlusion devices is largely driven by the growing number of patients affected by various chronic conditions. Additionally, rapid technological advancements, rising preference for minimally invasive surgeries (MIS), favorable reimbursement policies for MIS, and an expanding geriatric population are key factors contributing to the overall growth of the occlusion devices market between 2024 and 2030.

DelveInsight's "Occlusion Devices Market Insights, Competitive Landscape and Market Forecast-2030" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Occlusion Devices companies actively working in the market.

To know more about why North America is leading the market growth in the Occlusion Devices market, get a snapshot of the report Occlusion Devices Market Trends
https://www.delveinsight.com/sample-request/occlusion-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Occlusion Devices Overview
Occlusion devices are medical tools used to block or close blood vessels or other body passages to treat various conditions. They are commonly used in procedures such as closing abnormal blood flow pathways, sealing heart defects, or blocking blood supply to tumors. These devices can be made from materials like metal, polymer, or fabric and are often delivered through minimally invasive catheter-based techniques.

DelveInsight Analysis: The global occlusion devices market is projected to expand at a compound annual growth rate (CAGR) of 6.31% between 2024 and 2030.

Occlusion Devices Market Insights
Geographically, In 2023, North America is projected to hold the largest share of the occlusion devices market. This growth is driven by factors such as the increasing prevalence of cardiovascular diseases, rising cancer cases, and neurological conditions like brain aneurysms, alongside rapid advancements in device technology and new government initiatives promoting disease treatment awareness.

To read more about the latest highlights related to Occlusion Devices, get a snapshot of the key highlights entailed in the Occlusion Devices
https://www.delveinsight.com/report-store/occlusion-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Occlusion Devices Market Report
• In February 2022, Front Line Medical Technologies announced the launch and distribution of COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System), a device capable of withstanding aortic pressure while enabling permissive hypotension in areas below the balloon, reducing the risk of hemorrhage. It is the smallest life-saving device for bleeding control.
• In July 2021, Terumo Medical Corporation (TMC) announced the launch of its AZUR Vascular Plug, the only device compatible with a microcatheter that can occlude arteries up to 8 mm in diameter.
• In September 2020, Boston Scientific Corporation received FDA approval to launch the WATCHMAN FLX, a Left Atrial Appendage Closure (LAAC) device designed to seal the heart's left atrial appendage and prevent the formation of blood clots.
• Thus, owing to such developments in the market, rapid growth will be observed in the Occlusion Devices market during the forecast period

Key Players in the Occlusion Devices Market
Some of the key market players operating in the Occlusion Devices market include- Abbott, Acrostak Int., Terumo Corporation, Edwards Lifesciences Corporation, Cordis, B. Braun SE, Cook, Medtronic, Cardinal Health, AngioDynamics, Integer Holdings Corporation, Acandis GmbH, Penumbra, Inc., LeMaitre Vascular Inc., Lepu Medical, Stryker, Boston Scientific Corporation, Artio Medical Inc., KYOTO MEDICAL PLANNING Co., Ltd., Kaneka Medix Corporation, and others.

Which MedTech key players in the Occlusion Devices market are set to emerge as the trendsetter explore @ Key Occlusion Devices Companies
https://www.delveinsight.com/sample-request/occlusion-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Occlusion Devices Market Landscape
The COVID-19 pandemic had a considerable impact on the occlusion devices market, primarily due to the restructuring of healthcare systems in response to strict global lockdowns. Treating COVID-19 patients became the top priority, while individuals with chronic conditions, especially those with heart valve diseases, were classified as non-urgent, resulting in delays in their treatment procedures.
Additionally, factors such as blood vessel damage or trauma, smoking, hypertension, and genetic predisposition contribute to the risk of developing brain aneurysms. Treatment options include medical therapy, surgical clipping, endovascular therapy, or coiling, with or without adjunctive devices. For example, according to WHO statistics from August 2021, approximately 1.28 billion adults aged 30-79 worldwide had hypertension, with about two-thirds living in low- and middle-income countries. The rising prevalence of hypertension is expected to increase cardiovascular disease cases, thereby driving demand for occlusion devices used in cardiovascular treatments.
Consequently, due to these factors, the demand for neurology occlusion devices is anticipated to rise, contributing to overall growth in the occlusion devices market during the forecast period.

Scope of the Occlusion Devices Market Report
• Coverage: Global
• Study Period: 2021-2030
• Occlusion Devices Market Segmentation By Product Type: Sealants & Adhesives, Staplers, Sutures [Absorbable and Non-Absorbable], Hemostats, and Others
• Occlusion Devices Market Segmentation By End User: Hospitals, Clinics, and Others
• Occlusion Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Occlusion Devices Companies: Abbott, Acrostak Int., Terumo Corporation, Edwards Lifesciences Corporation, Cordis, B. Braun SE, Cook, Medtronic, Cardinal Health, AngioDynamics, Integer Holdings Corporation, Acandis GmbH, Penumbra, Inc., LeMaitre Vascular Inc., Lepu Medical, Stryker, Boston Scientific Corporation, Artio Medical Inc., KYOTO MEDICAL PLANNING Co., Ltd., Kaneka Medix Corporation, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Occlusion Devices market will grow by 2030? Click to get a snapshot of the Occlusion Devices Market Analysis
https://www.delveinsight.com/sample-request/occlusion-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.